Founded in 2011 by CEO John Ruprai, Ennogen is an international pharmaceutical and medical device company. Since it was established, Ennogen has developed a differentiated portfolio of over 150 Market Authorisations, holds the ISO13485 accreditation and is the legal manufacturer and distributor of a range of medical devices including various barrier ointments, creams and emollients.